Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Frontline Plc AGM Information 2024

Nov 14, 2024

6242_rns_2024-11-14_c212f211-c965-4e69-b750-fa3881bdf4f0.pdf

AGM Information

Open in viewer

Opens in your device viewer

FRONTLINE PLC

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS 12 TH DECEMBER 2024

NOTICE IS HEREBY given that the Annual General Meeting of Shareholders of Frontline plc (the "Company") will be held on 12 th December, 2024 at 09:00 a.m. at the Company's business office situated at Metis Tower, 28th October Avenue and Iakovou Tombazi Street, 4th floor, 3107 Limassol, Cyprus for the following purposes, all of which are more completely set forth in the accompanying information statement:

To receive and adopt the annual report and audited consolidated financial statements of the Company for the year ended December 31, 2023.

To consider the following Company proposals:

    1. To re-elect John Fredriksen as a Director of the Company.
    1. To re-elect James O'Shaughnessy as a Director of the Company.
    1. To re-elect Ola Lorentzon as a Director of the Company.
    1. To re-elect Cato Stonex as a Director of the Company.
    1. To re-elect Steen Jakobsen as a Director of the Company.
    1. To elect Ørjan Svanevik as a Director of the Company.
    1. To elect Dr. Maria Papakokkinou as a Director of the Company.
    1. To re-appoint PricewaterhouseCoopers of Limassol, Cyprus as auditors and to authorise the Directors to determine their remuneration.
    1. To approve the remuneration of the Company's Board of Directors of a total amount of fees not to exceed USD 600,000 for the year ended December 31, 2024.
    1. To approve with effect from 12:00 p.m. (Cyprus time) on 12 th December, 2024 (the "Effective Date") and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public against cash consideration, as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per share.
    1. To approve with effect from 12:00 pm (Cyprus time) on 12 th December, 2024 (the "Effective Date") and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public for cash consideration as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 debentures or other securities convertible into ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company or options or other securities carrying the right to subscribe for ordinary shares of the Company of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per security.
  • To approve on an advisory vote basis the Company's Remuneration Report for the year ended December 31st, 2023 pursuant to the provisions of the Encouragement of Long-Term Shareholders Engagement Law 111(I)/2021.

By Order of the Board of Directors

/s/ Marios Saveriades Secretary

14 th November, 2024.

Notes:

    1. The Board has fixed the close of business on 05th November, 2024 as the record date for the determination of the shareholders entitled to attend and vote at the Annual General Meeting or any adjournment thereof.
    1. No shareholder shall be entitled to attend unless written notice of the intention to attend, vote and/or submit questions with respect to the matters stated in the agenda in person or by proxy together with the power of attorney or other authority (if any) under which it is signed or a notarially certified copy of that power of attorney is sent to the Company Secretary, to reach the Registered Office at 8, John Kennedy Street, IRIS House, Office 740B, 3106 Limassol, Cyprus by not later than 48 hours before the time of holding the meeting.
    1. A Form of Proxy is enclosed for use by the holders of shares in connection with the business set out above.
    1. Any shareholder or shareholders which hold individually or collectively at least 5% of the total voting rights of all shareholders who have the right to vote shall have the right to add items to the agenda of the Annual General Meeting provided that each such item is accompanied by reasons which justify its inclusion or a draft resolution to be adopted in the general meeting and provided written notice of such an intention is received in written form at the registered office of the Company at 8, John Kennedy Street, IRIS House, Office 740B, 3106 Limassol, Cyprus at least 42 days prior to the date of the Annual General Meeting.
    1. Resolutions 1 9 set out above are Ordinary Resolutions, approval of which will require the affirmative vote of a simple majority of the votes cast. Resolutions 10 and 11 shall require the affirmative vote of 2/3rds of the votes corresponding to the represented issued share capital. If however at least half of the issued share capital is represented a simple majority of the votes cast shall be sufficient for approval. Resolution 12 will require the affirmative vote of a simple majority of the votes cast. However voting on this proposal is on an advisory basis only.
    1. Copies of (i) this Notice and Form of Proxy (ii) the audited consolidated financial statements of the Company for the year ended 31st December, 2023, included in its Annual Report (iii) a Directors' Report explaining the reasons for the proposed exclusion of the shareholders' right of pre-emption as per Proposals 10 and 11 hereabove (iii) a copy of the Remuneration Report of the Company for the year ended 31st December, 2023 (iv) copies of the proposed resolutions 1 – 12 hereabove and (v) the total number of shares and voting rights on the date of this Notice can be viewed in the Company's web-site www.frontlineplc.cy and/or can be collected from the Company's Registered Office at 8, John Kennedy Street, IRIS House, Office 740B, 3106 Limassol, Cyprus.

INFORMATION CONCERNING SOLICITATION AND VOTING FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS (THE "MEETING") OF FRONTLINE PLC TO BE HELD ON 12TH DECEMBER, 2024

PRESENTATION OF FINANCIAL STATEMENTS

In accordance with Section 142 of the Cyprus Companies Law Cap. 113, the audited consolidated financial statements and annual report of the Company for the year ended December 31, 2023 will be presented at the Meeting. These statements have been approved by the Directors of the Company. There is no requirement under Cyprus law that such statements be approved by shareholders, and no such approval will be sought at the Meeting.

The Company's audited consolidated financial statements contained in its Annual Report on Form 20-F are available on our website at www.frontlineplc.cy. Shareholders can request a hard copy free of charge upon request by writing to us at: 8, John Kennedy Street, IRIS House, Office 740B, 3106 Limassol, Cyprus.

COMPANY PROPOSALS

PROPOSALS 1, 2, 3, 4, 5, 6 and 7 - ELECTION OF DIRECTORS

The Board has nominated the six persons listed below for selection as Directors of the Company. Mr. Fredriksen, Mr. O'Shaughnessy, Mr. Lorentzon, Mr. Jakobsen and Mr. Stonex are presently members of the Board of Directors. Mr Svanevik and Dr. Papakokkinou shall be elected at the Board of the Company for the first time. Mr. Lorentzon, Mr. O'Shaughnessy and Mr Jacobsen meet the independence standard for directors established by the New York Stock Exchange and the United States Securities and Exchange Commission and the Cyprus Stock Exchange.

As provided in the Company's Articles of Association, each Director is elected at each Annual General Meeting of Shareholders and shall hold office until the next Annual General Meeting following his or her election or until his or her successor is elected.

Nominees For Election To The Company's Board Of Directors

Information concerning the nominees for Directors of the Company is set forth below:

John Fredriksen has served as a director of the Company since November 3, 1997. Mr. Fredriksen has established trusts for the benefit of his immediate family which indirectly control Hemen, our largest shareholder. Mr. Fredriksen was a director of Frontline 2012 at the date of the Merger. Mr. Fredriksen is also a director of a related party Golden Ocean Group Limited, a Bermuda company listed on Nasdaq and the OSE whose principal shareholder is Hemen.

James O'Shaughnessy has been a director and member of the Audit Committee of the Company since September 2018. James O'Shaughnessy served as an Executive Vice President, Chief Accounting Officer and Corporate Controller of Axis Capital Holdings Limited since March 26, 2012. Prior to that Mr. O'Shaughnessy has served as Chief Financial Officer of Flagstone Reinsurance Holdings and as Chief Accounting Officer and Senior Vice President of Scottish Re Group Ltd., and Chief Financial Officer of XL Re Ltd. at XL Group plc. Mr. O'Shaughnessy received a Bachelor of Commerce degree from University College, Cork, Ireland and is both a Fellow of the Institute of Chartered Accountants of Ireland and an Associate Member of the Chartered Insurance Institute of the UK. Mr. O'Shaughnessy earned a Master's Degree in Accounting from University College Dublin.

Ola Lorentzon has been director of the Company since May 2015. Mr. Lorentzon was the Managing Director of Frontline Management AS, a subsidiary of the Company, from April 2000 until September 2003. Mr. Lorentzon also serves as Director and Chairman of Flex LNG Ltd and Golden Ocean Group Ltd.

Steen Jakobsen has been a director of the Company since May 2022. Steen Jakobsen has served as a director of Flex LNG Ltd. since March 2021. Mr. Jakobsen joined Saxo Bank in 2000 and serves as Chief Investment Officer. Mr. Jakobsen was the founder of then Saxo Bank's renowned Outrageous Predictions. Prior to joining Saxo Bank, he worked with Swiss Bank Corp, Citibank, Chase Manhattan, UBS and served as Global Head of Trading, FX and Options at Christiania (now Nordea). Mr. Jakobsen graduated from the University of Copenhagen in 1989 with a MSc in Economics.

Cato Stonex has had a long career in Fund management, initially with J Rothschild Investment Management. He was then a founder partner of Taube Hodson Stonex (THS) for 20 years, which managed institutional portfolios of Global Equity mandates. THS was sold to GAM in 2016, since when he has established Partners Investment Company, which has focussed on stock picking in small and mid cap equities, largely in Europe. In 2021 Partners Investment Company became Stonex Capital Partners Ltd and that same year Mr Stonex also funded WMC Capital Ltd, an investment company focused on the recovery of the global shipping industry. He has also been involved in a range of other business areas. He has been a long term investor in German property and is a founder and director of Obotritia, a German conglomerate with interests in property, venture capital and banking. Since 2016 he has been a director of two Spanish property companies, Axiare and Arima, the first of which was sold in 2018 and the second which is listed on the Madrid stock exchange. He has a range of other private business interests.

He holds an undergraduate degree from the London School of Economics and Political Science, where he served for ten years as a Governor and is now an Emeritus Governor. He has chaired its Development Committee, and is now an advisor to the Endowment Investment Committee. He is closely involved with LSE Ideas, a leading academic think tank.

Ørjan Svanevik holds the position of investment director in Seatankers Management Norway. He has broad operational experience, including serving as CEO of Arendals Fossekompani, Head of M&A at Aker and Chief Operating Officer of Kværner, in addition to holding chair – and board positions in listed companies including Mowi, Volue, Seadrill and Archer. Today, Mr Svanevik is a board member of, among others, Axactor, Western Bulk and Paratus Energy. He holds an MSc in Economics and Business Administration (Siviløkonom) from the Norwegian Business School (BI), an MBA from Thunderbird and an AMP from Harvard.

Maria Papkokkinou holds the position of Chief Operation Officer and is a member of the Board of Directors of IXI Fund Managers Ltd, Cyprus and is also a non-executive Director in the Board of Directors of National Bank of Greece (Cyprus) Ltd. She has previously worked as Group Portfolio Manager in IKOS CIF Ltd, Cyprus, as Vice President of the Commodity Derivatives Desk in Citigroup London and as an associate at the FX and Commodities Trading Desk in JP Morgan Chase, London. She has an honors degree in Mathematics from Imperial College London, an MPhil in Financial Engineering from Sidney Sussex College UK and a PhD in Mathematical Finance from Imperial College, London.

PROPOSAL 8 - APPOINTMENT OF INDEPENDENT AUDITORS

At the Meeting, the Board will ask the shareholders to approve the re-appointment of PricewaterhouseCoopers of Limassol, Cyprus as the Company's independent auditors and to authorise the Board of Directors to determine the auditors' remuneration.

Audit services provided by PricewaterhouseCoopers, Limassol, Cyprus in fiscal year 2023 included the examination of the consolidated financial statements of the Company and its subsidiaries for the fiscal year ended 31st December, 2023.

All services rendered by the independent auditors are subject to pre-approval and review by the Audit Committee.

PROPOSAL 9 – TO APPROVE DIRECTORS' FEES

At the Meeting, the Board will ask that shareholders to approve the remuneration of the Company's Board of Directors of a total amount of fees not to exceed USD 600,000 for the year ended December 31, 2024.

PROPOSAL 10 – TO APPROVE THE EXCLUSION OF THE SHAREHOLDERS' RIGHT OF PRE-EMPTION WITH RESPECT TO ANY OFFER BY THE COMPANY TO THE PUBLIC OF ORDINARY SHARES OF THE COMPANY

At the Meeting the Board will ask that shareholders approve with effect from 12:00 pm (Cyprus time) on 12th December, 2024 (the "Effective Date") and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public against cash consideration as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per share.

Pursuant to the Cyprus Companies' Law and Article 21 of the Articles of Association all additional shares proposed to be issued for cash consideration shall, prior to issuance, be first offered to the existing shareholders in the nearest proportion to the number of shares already held by them at a date prescribed by the directors and such offer shall be made by a notice fixing the number of shares that provide a right to purchase shares which each shareholder is entitled to be allotted and restricting the time (which shall be not less than 14 days) in which the offer if not accepted shall be deemed as having been declined and under such circumstances the Directors may allot or otherwise dispose such shares in their discretion (the "Pre-Emption Right").

The Pre-Emption Right cannot be excluded or restricted in the Articles of Association, but only by a decision of the shareholders in General Meeting. If the directors propose to the General Meeting an exclusion or restriction of the Pre-Emption Right they have the obligation to submit to the general meeting a written report stating the reasons for the restriction or exclusion of the Pre-Emption Right and justifying the issuing price proposed (the "Directors Report"). The proposed restriction or exclusion may be specific to a specific proposed share issue or general provided that the maximum number of shares and the maximum period during which the relevant shares may be issued are indicated.

The reasons justifying the exclusion of the pre-emption right and the issue price are set out in the Director's Report dated 8 th November, 2024 which can be reviewed in the Company's website www.frontlineplc.cy or can be collected from the Company's Registered Office at 8, John Kennedy Street, IRIS House, Office 740B, 3106 Limassol, Cyprus.

PROPOSAL 11 – TO APPROVE THE EXCLUSION OF THE SHAREHOLDERS' RIGHT OF PRE-EMPTION WITH RESPECT TO ANY OFFER BY THE COMPANY OF SECURITIES CONVERTIBLE INTO ORDINARY SHARES OR SECURITIES CARRYING THE RIGHT TO SUBSCRIBE FOR ORDINARY SHARES OF THE COMPANY

At the Meeting the Board will ask that shareholders to approve with effect from 12:00 pm (Cyprus time) on 12th December, 2024 (the "Effective Date") and for a period of twelve (12) calendar months from the Effective Date the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public for cash consideration as may be decided by the Board of Directors from time to time, of a maximum of 377,377,111 debentures or other securities convertible into ordinary shares of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company or options or other securities carrying the right to subscribe for ordinary shares of the Company of nominal value USD 1 each ranking pari passu with the existing ordinary shares of the Company at a subscription price which shall be determined by the Board of Directors not lower than USD 1 per security.

The statutory provisions of the Cyprus Companies' Law and Article 21 of the Articles of Association relating to the exclusion of the shareholders' right of pre-emption with respect to any offer by the Company to the public of ordinary shares against cash consideration as explained in Proposal 10 apply equally to securities convertible into shares or securities carrying the right to subscribe for shares but not to the conversion of securities and the exercise of the right to subscribe.

The reasons justifying the exclusion of the pre-emption right and the issue price are set out in the Directors Report dated 8 th November, 2024 as specified in Proposal 9.

PROPOSAL 12 – TO APPROVE ON AN ADVISORY VOTE BASIS THE COMPANY'S REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31ST, 2023 PURSUANT TO THE PROVISIONS OF THE ENCOURAGEMENT OF LONG-TERM SHAREHOLDERS ENGAGEMENT LAW 111(I)/2021

At the meeting the Board will ask that shareholders approve on an advisory basis the Company's Remuneration Report for the year ended December 31st, 2023 pursuant to provisions of The Encouragement of Long-Term Shareholders Engagement Law 111(I)/2021 of the Republic of Cyprus (the "Law")

Pursuant to section 13(5)(a) of the Law the Annual General Meeting has the right to hold an advisory vote on the Remuneration Report of the last financial year and the Company shall explain in the next Remuneration Report how the vote of the general meeting was taken into account. As this is only an advisory vote a dissenting majority vote against approval of the Remuneration Report will have no practical effect. However, the Board is under an obligation to take the result of the voting under consideration during the implementation of the Company's Remuneration Policy for the following fiscal year.

OTHER BUSINESS

Management knows of no business that will be presented for consideration at the Annual General Meeting other than that stated in the Notice of Annual General Meeting.

By Order of the Board of Directors

/s/ Marios Saveriades Secretary

Limassol, Cyprus

Frontline plc (the "Company")

Form of Proxy for use at Annual General Meeting to be held on 12 th December, 2024

I/We …………………………………………………………………………………………………………. (NAME IN BLOCK CAPITALS) Of …………………………………………………………………………………………………………….

being (a) holder(s) of ………………………………………….Ordinary Shares of US\$1.00 each of the above-named

Company on the record date of 05 th November, 2024, hereby appoint the duly appointed Chairman of the Meeting or …………………………………………… to act as my/our proxy at the Annual General Meeting of the Company to be held on 12 th December, 2024, or at any adjournment thereof, and to vote on my/our behalf as directed below.

Please indicate with an X in the spaces provided how you wish your vote(s) to be cast on a poll. Should this card be returned duly signed, but without a specific direction, the proxy will vote or abstain at his or her discretion

Proposals For Against Abstain
1. To re-elect John Fredriksen as a Director of the Company.
2. To re-elect James O'Shaughnessy as a Director of the Company.
3. To re-elect Ola Lorentzon as a Director of the Company.
4. To re-elect Cato Stonex as a Director of the Company.
5. To re-elect Steen Jakobsen as a Director of the Company.
6. To elect Ørjan Svanevik as a Director of the Company.
7. To elect Dr. Maria Papakokkinou as a Director of the Company.
8. To re-appoint PricewaterhouseCoopers of Limassol, Cyprus as auditors and to authorize the Directors to
determine their remuneration.
9. To approve the remuneration of the Company's Board of Directors of a total amount of fees not to
exceed USD 600,000 for the year ended December 31, 2024.
10. To approve the exclusion of the shareholders' right of pre-emption with respect to any offer of new
ordinary shares of the Company to the public against cash consideration for a period
th December, 2024.
of twelve (12) calendar months with effect from 12:00 pm on 12
11. To approve the exclusion of the shareholders' right of pre-emption with the respect to any offer of
debentures or other securities convertible into ordinary shares or options or other securities carrying
the right to subscribe for ordinary shares of the Company to the public against cash consideration for a
th December, 2024.
period of twelve (12) calendar months with effect from 12:00 pm on 12
12. To approve on an advisory basis the Company's Remuneration Report for the year ended December
31st, 2023

Date ……………………………….. Signature ………………………………………………

Notes:

1. A Shareholder entitled to attend and vote at a meeting may appoint one or more proxies to attend and, on a poll, vote instead of him.

2. Proxies appointed by a single Shareholder need not all exercise their vote in the same manner.

3. In the case of joint holders, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders. For this purpose, seniority is determined by the order in which the names stand in the Register of Members.

4. In the case of a corporation, this proxy must be given under its common seal or be signed on its behalf by a duly authorised officer or attorney.

  • 5. If it is desired to appoint by proxy any person other than the Chairman of the Meeting, his/her name should be inserted in the relevant place, reference to the Chairman deleted and the alteration initialed.
  • 6. This proxy should be completed and be sent to reach one of the following addresses, as appropriate, by not later than 48 hours before the time for holding the meeting.

Nordea Bank AB (publ) filial i Norge Issuer Services PO Box 1166 Sentrum 0107 Oslo, Norway Fax: +47 2401 3462 or via e-mail to: [email protected]